MNST
56
9
ROK
52
-2
ACN
45
-4
MCHP
43
6
INTU
59
-3
XRAY
47
-2
MUR
34
-10
UHS
52
2
DIS
72
-5
CVS
31
2
FCX
50
-2
HST
58
-4
CCI
23
-2
NEM
46
-2
MCO
74
-3
PVH
60
2
XRX
52
3
NUE
39
-4
DNB
58
2
MU
42
7
MNST
56
9
ROK
52
-2
ACN
45
-4
MCHP
43
6
INTU
59
-3
XRAY
47
-2
MUR
34
-10
UHS
52
2
DIS
72
-5
CVS
31
2
FCX
50
-2
HST
58
-4
CCI
23
-2
NEM
46
-2
MCO
74
-3
PVH
60
2
XRX
52
3
NUE
39
-4
DNB
58
2
MU
42
7
Financhill
Back

BioNexus Gene Lab 10K Form

Sell
36

BGLC
BioNexus Gene Lab

Last Price:
0.26
Seasonality Move:
-23.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-08-12 10Q BGLC/BioNexus Gene Lab Quarterly
2021-05-18 10Q BGLC/BioNexus Gene Lab Quarterly
2021-03-30 10K BGLC/BioNexus Gene Lab Annual
2020-11-09 10Q BGLC/BioNexus Gene Lab Quarterly
2020-11-03 10Q BGLC/BioNexus Gene Lab Quarterly
2020-08-11 10Q BGLC/BioNexus Gene Lab Quarterly

Receive BGLC News And Ratings

See the #1 stock for the next 7 days that we like better than BGLC

BGLC Financial Statistics

Sales & Book Value

Annual Sales: $9.77M
Cash Flow: $-1.66M
Price / Cash Flow: 0
Annual Sales: $0.52
Price / Book: 0.5

Profitability

EPS (TTM): -0.07200
Net Income (TTM): $-941.6K
Gross Margin: $1.33M
Return on Equity: -9.89%
Return on Assets: -8.38%

BioNexus Gene Lab Earnings Forecast

Key BioNexus Gene Lab Financial Ratios

  • The Gross Profit Margin over the past 6 years for BGLC is 13.61%.
  • The Selling, General & Administrative Expenses for BGLC have been equal to 45.13% of Gross Profit Margin.
  • The Interest Expense is -0.53% of Operating Income.
  • The Net Earning history of BGLC is -26.91% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

BioNexus Gene Lab Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Trading Companies & Distributors
Sector: Industrials
Current Symbol: BGLC
Website: bionexusgenelab.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.98
Quick Ratio: 3.99

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BGLC Technical Analysis vs Fundamental Analysis

Sell
36
BioNexus Gene Lab (BGLC) is a Sell

Is BioNexus Gene Lab a Buy or a Sell?

  • BioNexus Gene Lab stock is rated a Sell
    The current BioNexus Gene Lab [BGLC] share price is $0.26. The Score for BGLC is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.